強
強気
強気 · 25%LPAA
$10.26
シナリオ価格
$11.015
0.000 (0.00%)終値時点
Loading chart…
- 高値
- 11.015
- 始値
- 11.015
- 出来高加重平均価格
- 11.02
- 出来高
- 106.00
- 時価総額
- —
- 安値
- 11.015
- 売買代金
- 1.17K
- EV/EBITDA（TTM）
- 0.00
Launch One Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It has not selected any business combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target. It has no operations nor generated any revenues.
AI分析 of Launch One Acquisition Corp (LPAA)
中立Currently, Launch One Acquisition Corp (LPAA) is not a strong buy. The stock is trading at $10.88, which is 34.2% of its 52-week range, indicating it is closer to its low of $10.47 than its high of $11.67. The RSI is at 58.868, suggesting it is nearing overbought territory, and the recent 5-day change is only +0.18%, showing limited momentum. The main risk is the low trading volume of 124 shares today compared to an average of 2678, which may indicate weak investor interest.
バリュエーション指標
Launch One Acquisition Corp（LPAA）の現在の予想PERは0.00で、5年平均は0.00です。
Alphio AI による LPAA の価格シナリオ
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト（25 / 50 / 25）であり、保証ではありません。
LPAA を保有するクジラ
イベントタイムライン
ニュース
8.501-13GlobenewswireMinovia Therapeutics Secures Two U.S. Patents Expanding Mitochondrial Therapy Technology
1.011-20GlobenewswireMinovia תציג את טכנולוגיית הגדלת מיטוכונדריה הטיפולית במצגת ובסדנה בכנס ובתערוכה השנתיים ה-67 של ASH
9.011-20GlobenewswireMinovia Therapeutics' Mitochondrial Augmentation Technology to be Highlighted in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
9.009-17GlobenewswireMinovia Therapeutics Obtains FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
9.009-17GlobenewswireMinovia Therapeutics Granted FDA Fast Track Status for MNV-201 in Treating Myelodysplastic Syndrome
LPAA のよくある質問 — Alphio AI が回答
Launch One Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It has not selected any business combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target. It has no operations nor generated any revenues. It operates in the Financials sector.
Currently, Launch One Acquisition Corp (LPAA) is not a strong buy. The stock is trading at $10.88, which is 34.2% of its 52-week range, indicating it is closer to its low of $10.47 than its high of $11.67. The RSI is at 58.868, suggesting it is nearing overbought territory, and the recent 5-day change is only +0.18%, showing limited momentum. The main risk is the low trading volume of 124 shares today compared to an average of 2678, which may indicate weak investor interest.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。